Channel Medsystems announced today that it appointed three new members to its executive team, including a new chief financial officer.
Berkeley, California-based Channel Medsystems named Ian Vawter as VP and CFO, Rebecca Furlong as VP and president of U.S. sales and Nital Patel Bryant as senior director of marketing.
Channel Medsystems develops the Cerene cryotherapy device for treating menstrual bleeding. The next-generation platform received FDA approval in July 2020 and the company said in a news release that the appointments follow a successful early commercial launch in September 2021.
Vawter joins with 25 years of financial experience, Channel Medsystems said, having most recently served as VP and CFO at Tepha, which was acquired by BD.
Furlong carries nearly three decades of experience in medical devices and pharmaceuticals, the company said, including work in women’s health. She most recently served as area VP of sales at Takeda.
Channel Medsystems said that Bryant’s diverse 20-year track record includes building brand recognition and sales momentum for medical devices, including women’s health products. She previously held the role of director of customer marketing at Grail.
“We are thrilled to have Ian, Rebecca and Nital join our management team, which will enable us to continue to build on the momentum of our early commercial success,” Channel Medsystems CEO Ric Cote said in the release. “Physician interest in and feedback on Cerene has been very encouraging and offers us early insights into the value this treatment can provide for women suffering from heavy menstrual bleeding. Patients and physicians alike are very receptive to having these procedures performed in the office.”
